Prahem Laboratories LLP
About Prahem Laboratories LLP
Data last updated:
Prahem Laboratories LLP is a limited liability partnership (LLP) based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 27 August 2018 and has been in existence for over 8 years.
The LLP is registered with the Registrar of Companies (ROC), Mumbai, under LLPIN AAN-1960. Its GSTIN is 27AAWFP4630R1Z8 (Maharashtra).
The LLP has a total obligation of contribution of ₹50,000. It is led by designated partners Hemil Kirti Shah and Pratik Kirti Shah.
Its latest statement of accounts is for the year ended 31 March 2025. The registered office is at 1202 Floor 12 Tower B Aaradhya Square Aaradhya One Earth, Ghatkopar Avenue Pant Nagar Ghatkopar East Mumbai 400075 Maharshtra India., Maharashtra, India – 400075.
As per the financials filed for FY 2024, the LLP reported a revenue of ₹54.97 Cr, a growth of 12% compared to the previous year. Revenue has grown at a compounded annual rate (CAGR) of 15% over three years and 101% over five years.
Court records list 1 case involving the LLP, including 1 filed against it.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered Address1202 Floor 12 Tower B Aaradhya Square Aaradhya One Earth, Ghatkopar Avenue Pant Nagar Ghatkopar East Mumbai 400075 Maharshtra India., Maharashtra, India – 400075
- IndustryPharma, Drug Formulation & Development, API Manufacturers
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Financials of Prahem Laboratories LLP FY 2025 filings available
Prahem Laboratories LLP reported revenue of ₹54.97 Cr (up 12% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Prahem Laboratories LLP
Revenue has grown at a compounded annual rate (CAGR) of 101% over five years, including 12% growth in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Prahem Laboratories LLP
| Statement of Account and Solvency | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Income and Expenditure | |||||
| Turnover | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Income | •••• | •••• | •••• | •••• | •••• |
| Purchases and Direct Costs | •••• | •••• | •••• | •••• | •••• |
| Personnel Expenses | •••• | •••• | •••• | •••• | •••• |
| Administrative Expenses | •••• | •••• | •••• | •••• | •••• |
| Interest | •••• | •••• | •••• | •••• | •••• |
| Depreciation | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax | •••• | •••• | •••• | •••• | •••• |
| Profit After Tax | •••• | •••• | •••• | •••• | •••• |
| Profit Transferred to Partners | •••• | •••• | •••• | •••• | •••• |
| Assets and Liabilities | |||||
| Partners' Contribution | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Secured Loans | •••• | •••• | •••• | •••• | •••• |
| Unsecured Loans | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Other Liabilities and Provisions | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Loans and Advances | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Prahem Laboratories LLP
| Statement of Account and Solvency | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| Net Profit Margin | •••• | •••• | •••• | •••• | •••• |
| Return on Partners' Funds | •••• | •••• | •••• | •••• | •••• |
| Return on Assets | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt to Partners' Funds | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Turnover Growth | •••• | •••• | •••• | •••• | •••• |
| Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form 8. The full year-wise statements and ratios of Prahem Laboratories are in the company report.
Financial statements from FY 2019
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Designated Partners of Prahem Laboratories LLP
Prahem Laboratories has 2 designated partners on record. No former designated partners are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Hemil Kirti Shah Also directs: Hiyana Pharmaceuticals India LLP, Ishpra Pharma LLP | Designated Partner | 27 Aug 2018 | 8 Years 1 Months | Current |
| Pratik Kirti Shah | Designated Partner | 27 Aug 2018 | 8 Years 1 Months | Current |
Peer Comparison of Prahem Laboratories LLP
Prahem Laboratories LLP is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Shreechem Pharmaceuticals Private Limited | ₹55.6 Cr (FY 2025) | •••• | •••• | 13.0% | •••• | Navi Mumbai, Maharashtra, India |
| Aerol Formulations Private Limited | ₹55.39 Cr (FY 2025) | •••• | •••• | 11.0% | •••• | New Delhi, Delhi, India |
| Cris Pharma (India) Limited | ₹55.24 Cr (FY 2024) | •••• | •••• | -4.0% | •••• | Jaipur, Rajasthan, India |
| Sndev Healthcare Limited | ₹55.17 Cr (FY 2025) | •••• | •••• | 14.0% | •••• | Kandivlai West, Maharashtra, India |
| Cu-V-Kar Genetic Medicine Private Limited | ₹55.11 Cr (FY 2024) | •••• | •••• | 38.0% | •••• | Chennai, Tamil Nadu, India |
| Prahem Laboratories LLP this company | ₹54.97 Cr (FY 2024) | •••• | •••• | 12.0% | •••• | Mumbai, Maharashtra, India |
| Kamla Lifesciences Limited | ₹54.89 Cr (FY 2024) | •••• | •••• | 115.0% | •••• | Boisar, Maharashtra, India |
| KRS Pharmaceuticals Private Limited | ₹54.79 Cr (FY 2025) | •••• | •••• | 60.0% | •••• | Hyderabad, Telangana, India |
| Zandra Life Sciences Private Limited | ₹54.64 Cr (FY 2025) | •••• | •••• | 12.0% | •••• | Mumbai, Maharashtra, India |
| Trimurti Distributors Private Limited | ₹54.27 Cr (FY 2025) | •••• | •••• | 1652.0% | •••• | Jalgaon, Maharashtra, India |
| Vim Meditech Private Limited | ₹53.98 Cr (FY 2024) | •••• | •••• | 13.0% | •••• | Ahmedabad, Gujarat, India |
Peers are the five companies nearest above and the five nearest below Prahem Laboratories by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Charges & Borrowings of Prahem Laboratories LLP
Prahem Laboratories LLP does not have any charges (loans) registered with the Registrar of Companies.
Legal Cases of Prahem Laboratories LLP
Prahem Laboratories LLP has 1 court case on record: 1 filed against it. All case is disposed. Status as checked on 21 Sep 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 1 | 1 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Bombay High Court | Court case (COMIP) | Filed against the company by Ajanta Pharma Limited | Disposed |
Full case history
All 1 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Employees and EPFO Compliance at Prahem Laboratories LLP
Employment history and EPFO contributions of people linked to Prahem Laboratories.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Prahem Laboratories LLP
Prahem Laboratories LLP has 2 designated partner changes on record since 2018: 2 appointments. The latest: Hemil Kirti Shah was appointed as Designated Partner on 27 Aug 2018.
Credit Ratings, Litigation & Regulatory Alerts for Prahem Laboratories LLP
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Prahem Laboratories LLP
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Prahem Laboratories LLP
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Prahem Laboratories LLP
Prahem Laboratories has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAWFP4630R1Z8 | Maharashtra | Active | 04 Jan 2019 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Prahem Laboratories LLP
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Prahem Laboratories LLP
Prahem Laboratories is an active limited liability partnership based in Mumbai, Maharashtra, India. The LLP works in drug formulation and development, within the pharma industry. It was incorporated on 27 August 2018 (8+ years old) and is registered under LLPIN AAN-1960.
Prahem Laboratories reported revenue of ₹54.97 Cr for FY 2024 (up 12% YoY).
Prahem Laboratories has 2 current designated partners:
- Hemil Kirti Shah - Designated Partner
- Pratik Kirti Shah - Designated Partner
The compounded annual growth rate (CAGR) of the revenue of Prahem Laboratories is 15% over three years and 101% over five years. In the latest year (FY 2024) revenue rose 12%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Prahem Laboratories is 27AAWFP4630R1Z8, registered in Maharashtra.
The LLPIN (Limited Liability Partnership Identification Number) of Prahem Laboratories is AAN-1960. It is issued by the Ministry of Corporate Affairs and uniquely identifies the LLP in India.
Prahem Laboratories has 1 court case on record: 1 filed against it.
Prahem Laboratories was incorporated on 27 August 2018, making it 8+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Prahem Laboratories by revenue are Shreechem Pharmaceuticals Private Limited, Aerol Formulations Private Limited, Cris Pharma (India) Limited, Sndev Healthcare Limited, Cu-V-Kar Genetic Medicine Private Limited and 5 more, all in the Pharma industry (Formulations).
Hemil Kirti Shah was appointed as Designated Partner on 27 Aug 2018. Pratik Kirti Shah was appointed as Designated Partner on 27 Aug 2018.
The registered office of Prahem Laboratories is at 1202 Floor 12 Tower B Aaradhya Square Aaradhya One Earth, Ghatkopar Avenue Pant Nagar Ghatkopar East Mumbai 400075 Maharshtra India., Maharashtra, India – 400075.